IP Library Granted Patent US 10,328,091
Granted Patent B2
US 10,328,091 · App. 15/522,575 · Granted Jun 25, 2019

Composition comprising Fut2-dependent oligosaccharides and Lacto-N-neotetraose for use in promoting brain development and cognition

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,328,091
App. No.
15/522,575
Granted
Jun 25, 2019
Kind
B2
Abstract

This invention relates to the use of a nutritional composition comprising Fut2-dependent oligosaccharides for promoting brain growth and development in infants in the very early postnatal period. The nutritional composition comprises Fut2-dependent oligosaccharides and Lacto-N-neotetraose and is specifically for use in promoting brain catch-up growth in preterm infants or infants with low-birth weight. The invention further relates to a kit comprising at least two of these nutritional compositions.

Claims (13)

1. A method for promoting brain growth and development in an infant between 0 and 4 months of age in need of brain catch-up growth, the method comprising administering a nutritional composition comprising 2′Fucosyllactose (2′FL) and Lacto-N-Neotetraose (LNnT) to the infant, the nutritional composition does not contain probiotics, and the amount of 2′-fucosyllactose is between 0.8-8.0 g/L of the nutritional composition.

2. The method according to claim 1 , wherein the infant is between 0 and 2 months of age.

3. The method according to claim 1 , wherein the nutritional composition is administered to the infant in an amount effective for achieving a characteristic selected from the group consisting of: head circumference growth rate in infants, brain catch-up growth in infants, cognitive function in infants, psychomotor development in infants, and any combination thereof.

4. The method according to claim 1 , wherein the nutritional composition provides nutrition to the infant.

5. The method according to claim 1 , wherein the nutritional composition is administered to the infant in addition to breast feeding.

6. The method according to claim 1 , wherein the Lacto-N-Neotetraose (LNnT) is 0.1 to 0.6 g/L of the nutritional composition.

7. The method according to claim 1 , wherein the nutritional composition further comprises at least one additional Fucosyltransferase 2 (Fut2)-dependent oligosaccharide selected from the group consisting of di-Fucosyllactose (diFL) and Lacto-N-fucopentaose I (LNFP I).

8. The method according to claim 1 , wherein the nutritional composition is in a form selected from the group consisting of an infant formula, a preterm infant formula, a human milk fortifier, a starter infant formula, a follow-on formula, a baby food formula, a medical food product for clinical nutrition and a supplement.

9. The method according to claim 1 , wherein the infant was born preterm or with low-birth weight or experienced intra-uterine growth retardation or suffered from growth stunting because of malnutrition and/or a disease.

10. The method according to claim 1 , wherein the infant was born from a mother with low Fut2 activity with a 2′Fucosyllactose concentration in breast milk of the mother of less than 0.2 g/L.

11. A method to provide nutrition to an infant between 0 and 4 months of age in need of brain catch-up growth, the method comprising feeding a nutritional composition comprising 2′Fucosyllactose (2′FL) and Lacto-N-Neotetraose (LNnT) to the infant, the nutritional composition does not contain probiotics, and the amount of 2′-fucosyllactose is between 0.8-8.0 g/L of the nutritional composition.

12. The method according to claim 1 , wherein the infant is between birth and 1 month of age, the Lacto-N-Neotetraose (LNnT) is 0.30 to 0.35 g/L of composition, and the 2′Fucosyllactose (2′FL) is 2.0 to 2.2 g/L of the nutritional composition.

13. The method according to claim 1 , further comprising adding the nutritional composition to breast milk from the mother of the infant prior to the administering.

Assignments (6)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 16, 2019
From: CASTRO, CARLOS DE; SPRENGER, NORBERT; THAKKAR, SAGAR
To: NESTEC S.A.,
Reel/Frame 049771/0511 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2017
From: DE CASTRO, CARLOS ANTONIO; SPRENGER, NORBERT; THAKKAR, SAGAR
To: NESTEC S.A.
Reel/Frame 043478/0241 →